-
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Study
EGAS50000000710
-
FOCUS Trial
Study
EGAS50000000725
-
Targeted_sequencing_of_in_vitro_colonies___bulks
Study
EGAS00001003175
-
HIPSD&R-seq enables scalable genomic copy number and transcriptome profiling
Study
EGAS50000000691
-
Whole-exome sequencing profiling of patients with metastatic prostate cancer at VHIO
Study
EGAS50000000736
-
Epstein-Barr Virus status drives morphological and molecular intra-tumour heterogeneity in gastric cancer: insights from a case report and literature review
Study
EGAS50000000706
-
Bladder cancer subtyping study across 4 atezo clinical trials
Study
EGAS50000000497
-
MET amplification in gastric cancer
Study
EGAS50000000744
-
Moles
Study
EGAS00001000789
-
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: CheckMate 649 biomarker analyses
Study
EGAS50000000747
-
An Integrated Approach to Patient Stratification and Therapy Selection in Acute Myeloid Leukemia
Study
EGAS00001004655
-
Clinical relevance of TCGA subtypes for gastric cancer patients
Study
EGAS50000000779
-
Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research
Study
EGAS50000000757
-
Djerroudi et al., E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000000761
-
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
Study
EGAS00001004660
-
A non-canonical lymphoblast in refractory childhood T-cell leukaemia
Study
EGAS50000000767
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Study
EGAS00001003427
-
MIBC NAC2020 cohort RNA sequencing
Study
EGAS50000000741
-
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
Study
EGAS50000000775
-
Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including MNX1 activation via deletion 7q
Study
EGAS50000000743
-
Oncogene activated human breast luminal progenitors contribute basally located myoepithelial cells
Study
EGAS50000000505
-
The phase II Neo-Pembro trial: neoadjuvant pembrolizumab in stage IV high-grade serous ovarian cancer
Study
EGAS50000000781
-
Stratton__WGS___RCC___Japan
Study
EGAS00001008001
-
Probabilistic cell type assignment of single-cell transcriptomic data reveals spatiotemporal microenvironment dynamics in human cancers
Study
EGAS00001003452
-
Clinical validity of post-surgery circulating tumor DNA (ctDNA) in stage III colon cancer patients treated with adjuvant chemotherapy: the PROVENC3 study
Study
EGAS50000000804
-
Germline WES of serrated polyposis syndrome
Study
EGAS50000000765
-
Blood-based monitoring of relapsed/refractory cHL patients predict responses to PD-1 blockade treatment
Study
EGAS00001005894
-
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
Study
EGAS50000000770
-
A Phase Ib/II Study of Regorafenib and Paclitaxel in Beyond First-line Advanced Esophagogastric Carcinoma (REPEAT)
Study
EGAS00001006054
-
EuroTARGET is a European study on mRCC, collecting clinical data, germline DNA, and tumor samples.
Study
EGAS50000000798
-
Longitudinal therapy monitoring of ALK-positive non-small cell lung cancer (copy number, cell-free DNA)
Study
EGAS00001004276
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
Chugai_colorectal_organoid_sequencing
Study
EGAS00001000872
-
Subclonal variation in patients with pediatric T-lymphoblastic leukemia (T-ALL)
Study
EGAS50000000794
-
ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types
Study
EGAS50000000807
-
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer
Study
EGAS50000000793
-
Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer
Study
EGAS50000000831
-
Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
Study
EGAS50000000809
-
Multisite_Primary_Breast_Cancer
Study
EGAS00001000891
-
Raw sequencing files from WGS and RNA-Seq
Study
EGAS50000000186
-
Spatial heterogeneity, stromal phenotypes, and therapeutic vulnerabilities in colorectal cancer peritoneal metastasis
Study
EGAS50000000813
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal_LCM
Study
EGAS00001003455
-
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals
Study
EGAS50000000715
-
Single-cell Transcriptome Profiling of Treatment-naïve and Post-treatment Colorectal Cancer: Insights into Putative Mechanisms of Chemoresistance
Study
EGAS50000000830
-
Tumor-resident T-cell regulate responses to checkpoint blockade immunotherapies
Study
EGAS50000000826
-
TRACERx 100: RRBS data from a subset of the first 100 TRACERx tumours
Study
EGAS00001003484
-
Spatial and temporal diversity in genomic instability processes define early stage lung cancer evolution.
Study
EGAS00001000840
-
WES in muscle-invasive bladder cancer (MIBC) treated with durvalumab plus olaparib in the neoadjuvant setting: NEODURVARIB trial
Study
EGAS50000000791
-
Integrative_genome_profiling_in_AML
Study
EGAS00001000858
-
Guardians_of_the_genome__protecting_DNA_from_endogenous_sources_of_damage_
Study
EGAS00001000874
-
A Comparative Analysis of Algorithms for Somatic SNV Detection in Cancer
Study
EGAS00001000927
-
65 prostate cancer cases WGS and transcriptome sequencing project
Study
EGAS00001000888
-
SeqControl: Process Control for DNA Sequencing
Study
EGAS00001000899
-
Von Hippel-Lindau syndrome multi-region exome sequencing project from two patients undertaken at Cancer Research UK's London Research Institute
Study
EGAS00001000907
-
METABRIC: Data from Batra et al (2021); DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation
Study
EGAS00001004327
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing
Study
EGAS00001000962
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
TGS___Comprehensive_Molecular_Characterization_of_Colorectal_Cancer_Metastases__MOSAIC_
Study
EGAS00001000958
-
CRLF2_sequencing_project_Exomes
Study
EGAS00001000081
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Therapeutic Resistance to PI3K-alpha Inhibitors
Study
EGAS00001000991
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Acute_Lymphoblastic_Leukemia_Sequencing
Study
EGAS00001000058
-
Ischemic stroke in a Swedish case-control study.
Study
EGAS00001000936
-
Accurate mutation detection in leukemia by re-sequencing a cancer gene set
Study
EGAS00001000268
-
Somatic_mutation_and_clonal_evolution_in_the_human_bladder_WES_NOVASEQ
Study
EGAS00001003456
-
Intra-tumor heterogeneity of localized lung adenocarcinomas defined by multi-region sequencing
Study
EGAS00001000930
-
Leeds_Melanoma_Cohort
Study
EGAS00001001158
-
RNA-sequencing of Non-muscle Invasive Bladder cancer (NMIBC)
Study
EGAS00001004358
-
Cell_lines_with_telomere_fusion_induced_rearrangements
Study
EGAS00001001059
-
Inferring tumor genomes from peripheral blood i.e. CTCs and plasma-DNA using deep sequencing and targeted enrichment
Study
EGAS00001000337
-
DKFZ-HIPO Project H021/NCT MASTER
Study
EGAS00001000948
-
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single nucleotide variants and tumoral heterogeneity by massively parallel sequencing
Study
EGAS00001000370
-
The genomic landscape of large and small tumors in early-onset prostate cancer patients
Study
EGAS00001000383
-
Colorectal_organoids_and_tumour_tissue___Whole_Genome_X10
Study
EGAS00001001100
-
Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers
Study
EGAS00001001112
-
Feasibility and safety of a multi-cancer blood test for screening and intervention
Study
EGAS00001004372
-
The Medical Genome Reference Bank: a whole genome data resource of 4,000 healthy elderly individuals.
Study
EGAS00001003511
-
Bone_Cancer___Rare_Types_Whole_Genome
Study
EGAS00001000501
-
Bisulphite_MPN_colonies
Study
EGAS00001003094
-
Signatures of Aristolochic Acid Mutagenesis in Bladder Cancer
Study
EGAS00001000975
-
SOFT_study___sequencing_premenopausal_breast_cancer
Study
EGAS00001000983
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
Study
EGAS00001001199
-
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
Study
EGAS00001001018
-
Quantification of chromosomal copy number aberrations by shallow whole-genome sequencing
Study
EGAS00001000642
-
GEL_WGS_Comparison
Study
EGAS00001000649
-
Genomic study of an AT-AML
Study
EGAS00001004392
-
Exploration of CNV’s and SNV’s in cancers with well-known genetic rearrangements: Identification of additional genetic changes in rearrangements-driven cancer
Study
EGAS00001000673
-
Whole exome sequencing reveals the mutational spectrum of testicular germ cell tumours
Study
EGAS00001001084
-
Capture Hi-C identifies the chromatin interactome of colorectal cancer risk loci
Study
EGAS00001001085
-
Sequencing of cell-free DNA from breast cancer patients
Study
EGAS00001004960
-
ESGI___Whole_Genome_Sequencing_of_samples_from_the_ORCADES_cohort__X10__
Study
EGAS00001001125
-
Genentech study of gallbladder cancer
Study
EGAS00001003004
-
mFAST-SeqS
Study
EGAS00001001133
-
Transposome_Bisulfite_Sequencing
Study
EGAS00001000751
-
FWO_project_G_0687_12_X10_WGS
Study
EGAS00001001145
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___single_cell_RNA_sequencing
Study
EGAS00001003519